CDK1 and adrenal cortex carcinoma: Furthermore, a study showed that cucurbitacin E (CurE), the CDK1 inhibitor, could trigger PANoptosis by regulating the interaction between CDK1 and ZBP1-PANoptosome in ACC cells [64].